Jeffrey A. Bailey

Trustee, HQH, HQL, THQ and THW (since 2020); CEO, IlluminOss Inc. (2018 to 2020); Vice President, Janssen Pharmaceutica (Johnson & Johnson) (1984-2006); Board Chairman, Aileron Therapeutics Inc. (since 2018); Director, Madison Vaccines, Inc. (since 2018); Director, BioDelivery Systems, Inc. (since 2020).

Rakesh K. Jain, PhD

Trustee, HQH, HQL (since 2007), THQ (since 2014) and THW (since 2015); Director, Steele Lab of Tumor Biology at Massachusetts General Hospital (since 1991); A.W. Cook Professor of Tumor Biology (Radiation Oncology) at Harvard Medical School (since 1991); Ad hoc Consultant/Scientific Advisory Board Member for pharmaceutical/biotech companies (various times since 2002); Ad hoc Consultant, Gershon Lehman Group (since 2004); Director, Co-Founder, XTuit Pharmaceuticals, Inc. (2012-2018).

Thomas M. Kent, CPA

Trustee, HQH, HQL, THQ and THW (since 2017); Partner, PricewaterhouseCoopers LLP (1989-2013); Director, Principal Global Investors Trust Co. (since 2014); Director, Thayer Academy (2009-2018); Director, New England Canada Business Council (since 2017).

Daniel R. Omstead, Ph*

Trustee, HQH, HQL (since 2003), THQ (since 2014) and THW (since 2015); President, HQH, HQL (since 2001), THQ (since 2014) and THW (since 2015); Chief Executive Officer and Managing Member, Tekla Capital Management LLC (since 2002).

Oleg M. Pohotsky, MBA, JD 

Trustee, HQH, HQL (since 2000), THQ (since 2014) and THW (since 2015); Consultant and Managing Partner, Right Bank Partners (since 2002); Adviser, Board Advisers, Kaufman & Co. LLC (since 2008); Director, Avangard Investment Holdings (since 2011); Director, The New America High Income Fund, Inc. (since 2013).

William S. Reardon, MBA

Trustee, HQH, HQL (since 2010), THQ (since 2014) and THW (since 2015); Partner, PricewaterhouseCoopers LLP (1973-2002); Independent Consultant (since 2002); Director, Idera Pharmaceuticals, Inc (since 2019).

Lucinda H. Stebbins, CPA, MBA 

Trustee, HQH, HQL (since 2006), THQ (since 2014) and THW (since 2015); Independent Consultant, Deutsche Bank (2004-2015); Director, Solstice Home Care, Inc. (since 2014).

* Trustee considered to be an “interested person” within the meaning of the Investment Company Act of 1940, as amended, through a position or affiliation with Tekla Capital Management LLC.